Incubation of human keratinocytes with gamma interferon (Y-IFN) induces the synthesis of a 53-kDa protein of unknoW"n nature and function. We report the identification of this protein through amino acid microsequencing. The NH2-terminal amino acid sequence of the 53-kDa antigen demonstrated that this protein was tryptophanyl-tRNA synthetase (Frolova et aI, Gene 109:291-296, 1991, Genbank accession number 61715). This result was validated by the sequencing of tryptic peptides. Identification of the 53-kDa y-IFN -induced protein was confirmed by immunoblotting with an antiserum directed against beef pancreas trypto-G amma interferon (y-IFN), which is synthesized and secreted by activated T lymphocytes, exerts a broad spectrum of biologic activities in target cells with properties similar to those of alpha and beta IFNs but [4 -6]. In inflammatory dermatoses characterized by an activated T-cell infiltrate, these molecules contribute to the direct activation of keratinocytes by production of pro-inflammatory cytokines and can profoundly influence the course of the local immune response [7 -9]. y-IFN interacts with keratinocytes in a biologicall y relevant fashion, because specific high-affinity receptors have been characterized on the keratinocyte cell membrane [10, 11] .
Incubation of human keratinocytes with gamma interferon (Y-IFN) induces the synthesis of a 53-kDa protein of unknoW"n nature and function. We report the identification of this protein through amino acid microsequencing. The NH2-terminal amino acid sequence of the 53-kDa antigen demonstrated that this protein was tryptophanyl-tRNA synthetase (Frolova et aI, Gene 109:291-296, 1991, Genbank accession number 61715). This result was validated by the sequencing of tryptic peptides. Identification of the 53-kDa y-IFN -induced protein was confirmed by immunoblotting with an antiserum directed against beef pancreas trypto-G amma interferon (y-IFN), which is synthesized and secreted by activated T lymphocytes, exerts a broad spectrum of biologic activities in target cells with properties similar to those of alpha and beta IFNs but with a greater efficiency (for review see [1 D. In the skin, y-IFN induces the synthesis and expression of HLA-DR antigens on keratinocytes [2, 3] as well as with other molecules such as the intercellular adhesion molecule-l (ICAM-l) and the IP-I0 protein [4 -6] . In inflammatory dermatoses characterized by an activated T-cell infiltrate, these molecules contribute to the direct activation of keratinocytes by production of pro-inflammatory cytokines and can profoundly influence the course of the local immune response [7 -9] . y-IFN interacts with keratinocytes in a biologicall y relevant fashion, because specific high-affinity receptors have been characterized on the keratinocyte cell membrane [10, 11] .
In vitro, y-IFN interferes with the biosynthesis of numerous products of the keratinocyte metabolism with consequential effects on cell behavior. Modulations ofkeratinocyte antigens involved either in the differentiation process such as cell-surface glycoproteins [12, 13] or in cell adhesion such as fibronectin [14] , thrombospondin [1 5] , and bullous pemphigoid antigens [16] are evidence of drastic modifications of the normal keratinocyte metabolism upon stimulation with y-IFN. Moreover, specific sets of proteins are induced by y-IFN in various cells including human keratinocytes [17 -20] , including in particular, the biosynthesis of a 53-kDa protein [20, 21] . Manuscript received July 6, 1992; accepted for publication February 3, 1993 .
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Abbreviations: CAPS, 3-cyclohexylamino-1-propanesulfonic acid; ICAM-l, intercelluar adhesion l11olecule-l; y-IFN, human recombinant gamma interferon; IU, international unit; PVDF, polyvinylidene difluoride.
phanyl-tRNA synthetase. Northern blot analysis using a synt1. 1etic oligonucleotidic 32P-labeled probe evidenced a 3.1-kb transcript in y-IFN -treated cells indicating that the gene was regulated at the pre-translational level.
These data show that y-IFN potently induces in keratinocytes the expression of an enzyme directly involved in protein biosynthesis. Elevated levels of tryptophanyl-tRNA synthetase in treated cultured keratinocytes might be involved in the cell-growth -inhibitory activity of gamma interferon. ] InJlest DermatoI100: 775 -779, 1993 The model of expression of this component, which is localized in the cell cytoplasm, has been previously determined [21] . However, the nature and the biologic significance of this y-IFN -induced protein are still unknown [20, 21] . In the experiments reported here we show that the 53-kDa protein is tryptophanyl-tRNA synthetase and that induction of tryptophanyl-tRNA synthetase protein by y-IFN reflects induction of specific mRNA.
MATERIALS AND METHODS
Cell Culture Human epidermal cell cultures were prepared from breast skin removed during plastic surgery. Primary cultures ofkeratinocytes were grown on 3T3 feeder layers [22] . Subcultures were obtained by seeding culture dishes at 2 X 10 4 cells/cm 2 on irradiated 3T3 cells. Culture medium was as previously described [1 2], a 3 : 1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium, supplemented with 10% fetal calf serum, hydrocortisone 0.4 J1g/ml, insulin 5 J1g/ml, triiodothyronine 2 X 10-9 M, choleragen 10-10 M, epidermal growth factor 10 ng/ml, and antibiotics. Cultures were maintained at 37°C in 5% CO 2 , Under these conditions, a confluent layer of epidermal cells was obtained within 1 week. At this time, some cultures were maintained in the same medium; others were exposed to y-IFN (Amersham International Pic, Buckinghamshire, England , specific activity 1.7 X 10 7 lui mg), 100 IU/ml culture medium. Medium was changed dail y. All experiments were carried out on first-passage cells.
Protein Extraction and Polyacrylamide Gel Electrophoresis Epidermal cell cultures were rinsed with phosphate-buffered saline on ice, and the cells were scraped into extraction buffer: 0.05 M Tris-HCl, pH 7.5, 0.15 M NaCl , 0.5% Nonidet P-40 (NP-40),10 mM ethylenediaminetetraacetic acid, 1 mM phenylme~hyl sulfonyl fluoride,S mM N-ethylmaleimide, and 1 J.lg/ ml aprotlI1ln. Cultures were ground at 4 ° C by 30 strokes in a Teflonl glass homogenizer and the homogenate was briefly sonicated. After centnfuga-0022-202X/93/S06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 775 tion (13, 000 Xg, 4°C, 15 min), the supernatant was collected and stored at -70°C.
Sodium dodecylsulfate -polyacrylamide gel electrophoresis was performed on slab gels using the system of Laemmli [23] modified by the use of 5 -15 or 8 -12% gradients of polyacrylamide [12] .
N-Terminal Amino-Acid Sequencing NP-40 soluble proteins from 8-d y-IFN -treated cultures were run on 8 -12%, 1-mm-thick gradient gels, then electrophoretically transferred onto polyvinylidene difluoride (PVDF) membranes (Immobilon, Millipore Corp., Bedford, MA) in 0.1 M CAPS pH 10, 10% methanol buffer. Proteins were visualized by Coomassie Brilliant blue R250 staining (Serva, Heidelberg, Germany), and the 53-kDa band was carefully excised using a sharp blade. After further washings in H 2 0, the 53-kDa protein containing PVDF bands were stored at -70°C until N-terminal amino acid analysis.
The N-terminal sequence determination was performed by Edman degradation using a 470-A Applied Biosystems gas phase sequencer. Phenyl thiohydantoin (PTH) amino acids were identifi ed on-line with a 120-A Applied Biosystems PTH-Analyzer. An IBM PC-AT microcomputer was connected to the PTH-Analyzer and was used to quantify the PTH amino acids by means of the System Gold software (B~kman). All the products and reagents used for sequencing were from Applied Biosystems (Foster City, CAl·
Before sequencing, the Immobilon pieces were cut into 1 X 1 mm pieces and placed into the cartridge of the sequencer; no polybrene-treated glass fiber filters were used. The sequencing was performed using the 03RPTH program provided by Applied Biosysterns, with slight modifications. Chemical delivery rates were carefully monitored during the sequence determination.
The quantity of PTH-proline at the first cycle was 12-14 pmoles; nevertheless, as the exact amount of material loaded on the sequencer was not known, the initial yield could not be calculated. The repetitive yield was determined through semi-logarithmic regression analysis of all identified PTH amino acids, except PTHSer, which· were recovered in low yield. The repetitive yield was between 88 and 93%.
Internal Amino Acid Sequence Determination The 53-kDa protein contained on PVDF membranes was in situ digested by trypsin according to Bauw et a1 [24] . Briefly, pieces ofPVDF bands were treated for 30 min with 400 pi of a 0.2% polyvinylpyrrolidone solution 111 methanol; then an equal volume of water was added and the supernatant discarded after 10 min. PVDF pieces were washed four times with water and once with 0.1 M Tris HCI pH 8.5 buffer. They were replaced in 100 pi of the same buffer; 1 pi of a trypsin solution (1 mg/ml) was added and the digestion proceeded for 6 hat 37°C. Then the supernatant was collected and the PVDF pieces were washed with 100 pi of 80% formic acid and four times with 100 pi of water; all the washing solutions were added to the digestion mixture.
The pep tides contained in the combined washing solutions were separated by reversed-phase high-performance liquid chromatography, using a C8 Aquapore RP300 column (22 X 0.4 cm; Browmlee) and a linear gradient of acetonitrile in 0.1 % trifluoroacetic acid. Eluting peptides were detected by UV absorbance at 214 nm, collected in Eppendorf tubes, and stored at -20°C prior to sequence analysis.
Peptides were loaded on a polybrene-treated glass fiber filter and amino acid determinations were performed with the equipment described above.
Computer Search for Identity The amino' acid sequence homology searches were carried out using the Bisance computer program of CiTi 2 for screening protein databases [25] . The protein database was Genbank (release 73, September 1992).
Immunoblotting The proteins from unstained gels were transferred electrophoretically to nitrocellulose membranes (Schleicher & Schuell BA 86) essentially according to the immunoblot tech-THE JOURNAL OF INVESTIGATIVE DERMATOLOGY nique described by Towbin et al [26] . In these assays, the polyclonal antibody to beef pancreas tryptophanyl-tRNA synthetase was diluted to 1/50,000. Non-fat powdered milk 5% in Tris-buffered saline [10 mM Tris HCI, pH 7.6,140 mM NaCI (TBS)] was used to saturate the free-binding capacity of the nitrocellulose membrane.
For immunodetection of the antigens, the sheets were incubated at room temperature for 2 h in diluted antibody, washed for 1 h in six changes of washing buffer (0.5% NP-40 in TBS), and incubated for 2 h with peroxidase-labeled Fab goat anti-rabbit IgG (Biosys, Compiegne, France). After further washings, the specific staining reaction was visualized with 3-3' diaminobenzidine (0.05 mg/ml) and 0.03% H 2 0 2 in 100 mM Tris HCl, pH 7.6. Controls were obtained by using the preimmune serum or by omitting the first layer antibody.
RNA Isolation and Northern Blotting Analysis A singlestrand oligonucleotide probe (30 mer) synthesized from the nucleotide sequence of the cDNA encoding for human tryptophanyltRNA synthetase (nucleotide + 1577 to + 1606) [27] was used to characterize mRN As specific for the protein by Northern blot analysis. A specific probe for human P actin was purchased from Oncogene Science (Manhasset, NY). These probes were 5' end labeled with y32P ATP (3000 Ci/mmol, Amersham) using T4 polynucleotide Kinase (Appligene, Strasbourg, France). Oligolabeling was done according to Miyada's method [28] and labeled probes were purified on Sephadex G25 column (Pharmacia LKB Biotechnology, Uppsala, Sweden). Labeled oligoprobes were eluted using TNE buffer (10 mM Tris-HCI, pH 7.5 100 mM NaCI, 1 mM ethylemediaminetetraacetic acid) . Specific activity was typically in the range 2.5 to 5 X 10 8 cpm/pg. Total cellular RNA was prepared from keratinocytes grown with or without y-IFN (100 IU/ml) for 48 h, according to the method developed by Chomczynski and Sacchi [29] and estimated by absorbance at 260 nm. Isolated total RNA was electrophoresed in a 1.2% agarose gel with 6.5% formaldehyde and 48.5% formamide, then transferred onto a nylon membrane (Hybond-N, Amersham). The Hybond-N sheets were baked at 80°C for 30 min, then pre-hybridized at 65°C for at least 1 h. The pre-hybridization solution contained 10% Dextran sulfate, 1 % sodium dodecylsulfate, 100 pg/mJ of denatured non-homologous DNA (i.e. , salmon sperm DNA) in 1 M NaCI, 50 mM Tris-HCI buffer, pH 7.5. Hybridization was performed overnight at 65°C in the above mixture supplemented with the 32P-labeled oligonucleotide probe (1 X 10 6 cpm/ml hybridization buffer). The filters were washed 4 times with 2 X sodium citrate/sodium chloride buffer, 0.1 % sodium dodecylsulfate at room temperature; the last washing was done without sodium dodecylsulfate. The filters were then exposed to Amersham films in the presence of intensifying screens for 24 hand 3 d.
RESULTS

Identification of the y-IFN -induced 53-kDa Protein by
Microsequencing Sodium dodecylsulfate -polyacrylamide gel electrophoresis analysis of NP-40 keratinocyte-stratified culture extracts revealed the presence of numerous protein bands distributed over a wide range of M, (Fig la-d) . Comparison of protein profiles from cultures grown with (Fig lc,d) or without (Fig la,b) y-IFN (100 IU /ml) showed subtle differences in the high and low M,s. However, the most prominent change was the large amount of a 53-kDa protein, which was selectively altered ill extracts from treated cultures. From NH2-terminal sequence analysis the following sequence was identified: PNSEPASLLELXNSIAXQ. Comparison of this sequence with those available in databank revealed complete homology to human tryptophanyl-tRNA synthetase, EC number "6.1. situ trypsin d igestion of the 53-kDa protein-containing PVDF band s W"e re subjected to microsequencing. As shown in T able I, the sequ e nces of these five peptides m atch exactly partial internal sequences of human tryptophanyl-tRNA sy nthetase, corresponding to fra gme nts 142 -162, 205 -220, 27 8 -298, 350 -366, and 433 -448 , r e spective ly [27] .
ConfirlDation of the Identification of the y-IFN -induced
Protein as Tryptophanyl-tRNA Synthetase by Immunoblotting To confirm that tryptophanyl-tRNA synthetase is induced by y-IFN, w e raised an antiserum against beef pancreas tryp- • T h e a m i no acid residues arc given in t he onc·lettcr notatio n. X I no PTH-amino acid could be d e t ected. ?, the corresponding residue could not be identified due to a PTHAna lyzer failure.
I NUlTle r a tion of residues corresponds to the sequence of human try ptophanyl-tRNA tophanyl-tRNA synthetase [30] and used it to probe a blo tofNP-40 soluble proteins fro m human keratinocytes treated with control medium o r y-IFN (Fig 2) . In an immunoblot of extract from y-IFN -treated keratinocy te cultures, the antiserum strongly reacted with a pro tein band of m olecular mass 53 kD a (Fig 2b' ). When blotted on extract from epidermal cel l cultures grow n in the absence of y-IFN, the antise rum fai led to detect any protein (Fig 2a' ).
Northern Blotting. T o charac terize the y-IFN -induced 53-kDa protein specific transcript in human keratinocytes. we performed Northern blot analys is. Because it w as dem onstrated that this protein is tryptophanyl-tRNA synthetase. we used a single-strand o ltgo nucleotide probe sy nthes ized from the sequence of the eDNA encoding for human tryptophanyl-tRNA synthetase [27] . In these experiments a -3.1-kb transcript was found in y-IFN -treated cells (Fig 3d,e,f) . whereas it was no t detected in keratinocytes grow.n 1Il control medium (Fig 3a,b,c ). H owever, N orthern blot analYSIS of poly{A)+ RNA revea led a fa int ex press io n of tryptophanyl-tRNA sy nthetase tra nscripts in control keratinocytes (results not shown).
DISCUSSION
W e demonstrate that the 53-kDa protein induced in human keratinocytes by y-IFN is tryptophanyl-tRNA synthetase and that 1l1duc-tion of the protein is a consequence of induction of tryptophanyltRNA synthetase mRNA. . It was recentl y reported that the )'2 protein induced by y-IFN 1Il transformed human amnion cells was highly ho mologous to rabbit peptide chain release fa ctor and bovine tryptophanyl-tRNA sy nthetase [31] . T ryptophanyl-tRNA synthetase was also demonstrated in The binding of a p actin probe is shown at the bollom.
human fibroblasts [32] , macrorhages, and epithelial-like amniontissue -derived cell line [33,34 after y-IFN treatment. The cDNAdeduced amino acid sequences of these proteins were identical. It thus appears that y-IFN up-regulates the same protein product in various human cell types. This protein not only has sequence homology but also the enzymatic activity of tryptophanyl-tRNA synthetase [31-33J. Our findings indicate that epidermal keratinocytes have to be added to the list of cells in which the gene that encodes tryptophanyl-tRNA synthetase is up-regulated by y-IFN. lndoleamine 2,3-dioxygenase, an enzyme involved in the degradation pathway of tryptophan, is also induced by y-IFN. Its induction leads to a depletion of the cellular tryptophan pool and seems to represent an effective means of regulating cell growth [35 ,36] . However, demonstration of induction of indoleamine 2,3-dioxygenase in keratinocytes by y-IFN has not yet been reported, although this cytokine is known to reduce epidermal cell proliferation.
As tryptophanyl-tRNA synthetase shows, near identity with peptide chain release factor [27, [31] [32] [33] [34] 37] and has release-factor activity [34] , we can therefore imagine that, within the cell, the 53-kDa protein may function as a tryptophanyl-tRNA synthetase or as a release factor or possibly as both. Though it is as yet difficult to explain how the 53-kDa protein is involved in the biologic actions of y-IFN, we can envisage a role in the protein-synthesizing machinery. In y-IFN -treated cells, the high release-factor activity might induce frequent detachment of premature polypeptides from the ribosomes, leading to accumulation of proteins with incomplete biologic functions. On the other ?and, tryptophanyl-tRNA synthetase is shown to be closely assoCIated with DNA polymerase [38] ; moreover, aminoacyl-tRNA synthetases generate diadenosine 5' ,Sill_Pi ,p 4 -tetraphosphate, which accum ul ates in cell contact growth-inhibited cells [39J. It is thus tempting to speculate about some involvement of tryptop hanyl-tRNA synthetase in the potent antiproliferative action of y-IFN. However, in the skin, the keratinocyte metabolism and behavior depend on multiple signals that can operate in a synergistic or antagonistic way to modulate tryptophanyl-tRNA synthetase expression.
As autoantibodies against this enzyme have been reported in sera of patients bearing autoimmune diseases [40] , this immune response might represent an interesting biologic parameter of inflammation in various diseases.
. Finding out how the tryptophanyl-tRNA synthetase y-IFN- 
